HomeOpen Access NewsParkinsons Disease

Parkinsons Disease

Parkinson’s disease trigger observed in human brain tissue for the first time

Scientists have directly visualised alpha-synuclein oligomers in human brain tissue, a key trigger in Parkinson's disease.

Treatments and symptoms of Parkinson’s

Prof. David Dexter, deputy director of research at Parkinson’s UK shares his thoughts on the symptoms of Parkinson’s and the chances of finding a cure

What’s new in Parkinson’s rating scales?

Parkinson’s rating scales are a vital assessment tool, but have their limitations. Jennifer Stratten explains how and why the EPDA developed a new one

World Parkinson’s Day: uniting to raise awareness

Today, stakeholders from across the globe will unite to raise awareness of Parkinson’s during a dedicated campaign

The role of physiotherapy for Parkinson’s

Writing on behalf of the Chartered Society of Physiotherapy, Dr. Bhanu Ramaswamy highlights how physiotherapy can help manage the symptoms of Parkinson’s

How the retreat of big pharma leads to lost opportunities for Parkinson’s drug discovery

The changing pharma landscape means opportunities for Parkinson's drug discovery are missed, but Parkinson's UK has a new strategy to redress the balance This will...

Time for a change of tack on drug development for neurodegenerative diseases?

UCB's Duncan McHale outlines why reclassification might be a good idea to boost drug development for neurodegenerative diseases like Alzheimer's and Parkinson's Neurodegenerative diseases are...

A stem cell solution for Parkinson’s?

Claire Bale, Communications Manager for Parkinson’s UK, highlights the latest thinking in stem cell research for the potential treatment of Parkinson’s. Stem cells can develop...

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders